
Alkem Laboratories Limited has informed the Exchange regarding a revised press release dated Jun 10, 2021, titled "ALKEM launches Perampanel Tablets in India under the brand name Perampil for treatment of Epilepsy.".
Filed with NSE ·

Alkem Laboratories Limited has informed the Exchange regarding a revised press release dated Jun 10, 2021, titled "ALKEM launches Perampanel Tablets in India under the brand name Perampil for treatment of Epilepsy.".
6ix hasn’t read this filing yet.
Alkem Laboratories Ltd. on 6ix
Follow Alkem Laboratories into a list and get an email when it puts out news.
Follow Alkem Laboratories